These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 12102724)

  • 61. Immunoglobulin-G Glycation by Fructose Leads to Structural Perturbations and Drop Off in Free Lysine and Arginine Residues.
    Faisal M; Alatar AA; Ahmad S
    Protein Pept Lett; 2017; 24(3):241-244. PubMed ID: 28124608
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Identity and localization of advanced glycation end products on human beta2-microglobulin using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
    Cocklin RR; Zhang Y; O'Neill KD; Chen NX; Moe SM; Bidasee KR; Wang M
    Anal Biochem; 2003 Mar; 314(2):322-5. PubMed ID: 12654321
    [No Abstract]   [Full Text] [Related]  

  • 63. Peptide and amino acid glycation: new insights into the Maillard reaction.
    Horvat S; Jakas A
    J Pept Sci; 2004 Mar; 10(3):119-37. PubMed ID: 15113085
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Optimizing glycation control in diabetes: An integrated approach for inhibiting nonenzymatic glycation reactions of biological macromolecules.
    Song H; Ma H; Shi J; Liu Y; Kan C; Hou N; Han J; Sun X; Qiu H
    Int J Biol Macromol; 2023 Jul; 243():125148. PubMed ID: 37268079
    [TBL] [Abstract][Full Text] [Related]  

  • 65. N(ε)-Carboxymethyl Modification of Lysine Residues in Pathogenic Prion Isoforms.
    Choi YG; Shin HY; Kim JI; Choi EK; Carp RI; Kim YS
    Mol Neurobiol; 2016 Jul; 53(5):3102-3112. PubMed ID: 25983034
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Intrinsic toxicity of glucose, due to non-enzymatic glycation, is controlled in-vivo by deglycation systems including: FN3K-mediated deglycation of fructosamines and transglycation of aldosamines.
    Szwergold BS
    Med Hypotheses; 2005; 65(2):337-48. PubMed ID: 15922110
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Alpha-thiolamines such as cysteine and cysteamine act as effective transglycating agents due to formation of irreversible thiazolidine derivatives.
    Szwergold BS
    Med Hypotheses; 2006; 66(4):698-707. PubMed ID: 16359826
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [The glucose, glycotoxins and glycation products: the involvement into pathogenesis of microangiopathies, arteriolosclerosis and atherosclerosis].
    Titov VN; Shiriaeva IuK
    Klin Lab Diagn; 2011 Nov; (11):3-13. PubMed ID: 22312908
    [TBL] [Abstract][Full Text] [Related]  

  • 69. N-terminal glycation of proteins and peptides in foods and in vivo: evaluation of N-(2-furoylmethyl)valine in acid hydrolyzates of human hemoglobin.
    Penndorf I; Li C; Schwarzenbolz U; Henle T
    Ann N Y Acad Sci; 2008 Apr; 1126():118-23. PubMed ID: 18448804
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Gas-phase rearrangement reaction of Schiff-base-modified peptide ions.
    Wang N; Pilo AL; Zhao F; Bu J; McLuckey SA
    Rapid Commun Mass Spectrom; 2018 Dec; 32(24):2166-2173. PubMed ID: 30280440
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Screening for glucose-triggered modifications of glutathione.
    Jerić I; Horvat S
    J Pept Sci; 2009 Aug; 15(8):540-7. PubMed ID: 19579211
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Oxidative degradation of N(ε)-fructosylamine-substituted peptides in heated aqueous systems.
    Greifenhagen U; Frolov A; Hoffmann R
    Amino Acids; 2015 May; 47(5):1065-76. PubMed ID: 25712730
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Lipid glycation and protein glycation in diabetes and atherosclerosis.
    Miyazawa T; Nakagawa K; Shimasaki S; Nagai R
    Amino Acids; 2012 Apr; 42(4):1163-70. PubMed ID: 20957396
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Glycation of lysine-containing dipeptides.
    Mennella C; Visciano M; Napolitano A; Del Castillo MD; Fogliano V
    J Pept Sci; 2006 Apr; 12(4):291-6. PubMed ID: 16180244
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The effect of an insulin releasing agent, BTS 67582, on advanced glycation end product formation in vitro.
    Simpson AE; Jones RB
    Life Sci; 1999; 64(16):1427-34. PubMed ID: 10321722
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Chromatographic assay of glycation adducts in human serum albumin glycated in vitro by derivatization with 6-aminoquinolyl-N-hydroxysuccinimidyl-carbamate and intrinsic fluorescence.
    Ahmed N; Thornalley PJ
    Biochem J; 2002 May; 364(Pt 1):15-24. PubMed ID: 11988071
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Quantitative screening of advanced glycation endproducts in cellular and extracellular proteins by tandem mass spectrometry.
    Thornalley PJ; Battah S; Ahmed N; Karachalias N; Agalou S; Babaei-Jadidi R; Dawnay A
    Biochem J; 2003 Nov; 375(Pt 3):581-92. PubMed ID: 12885296
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Diet-derived advanced glycation end products or lipofuscin disrupts proteostasis and reduces life span in Drosophila melanogaster.
    Tsakiri EN; Iliaki KK; Höhn A; Grimm S; Papassideri IS; Grune T; Trougakos IP
    Free Radic Biol Med; 2013 Dec; 65():1155-1163. PubMed ID: 23999505
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Lipoxidation products as biomarkers of oxidative damage to proteins during lipid peroxidation reactions.
    Requena JR; Fu MX; Ahmed MU; Jenkins AJ; Lyons TJ; Thorpe SR
    Nephrol Dial Transplant; 1996; 11 Suppl 5():48-53. PubMed ID: 9044307
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Glycation, glycoxidation, and cross-linking of collagen by glucose. Kinetics, mechanisms, and inhibition of late stages of the Maillard reaction.
    Fu MX; Wells-Knecht KJ; Blackledge JA; Lyons TJ; Thorpe SR; Baynes JW
    Diabetes; 1994 May; 43(5):676-83. PubMed ID: 8168645
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.